Cargando…

Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost

PURPOSE OF REVIEW: With the rise in prevalence of youth-onset type 2 diabetes (T2DM), it is imperative to understand the clinical burden of the disease and the socioeconomic burden this disease imposes. We review the most recent data on youth-onset T2DM, including its pathophysiology, complications,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriquez, Isabella Marranzini, O’Sullivan, Katie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037371/
https://www.ncbi.nlm.nih.gov/pubmed/36961664
http://dx.doi.org/10.1007/s11892-023-01501-7
_version_ 1784911863787552768
author Rodriquez, Isabella Marranzini
O’Sullivan, Katie L.
author_facet Rodriquez, Isabella Marranzini
O’Sullivan, Katie L.
author_sort Rodriquez, Isabella Marranzini
collection PubMed
description PURPOSE OF REVIEW: With the rise in prevalence of youth-onset type 2 diabetes (T2DM), it is imperative to understand the clinical burden of the disease and the socioeconomic burden this disease imposes. We review the most recent data on youth-onset T2DM, including its pathophysiology, complications, and treatment. We also review existing data to determine the socioeconomic burden of youth-onset T2DM. RECENT FINDINGS: The incidence of youth-onset T2DM is rising, and significantly accelerated following the COVID-19 pandemic. Youth with T2DM are more frequently from families of racial/ethnic minorities and lower socioeconomic status. Youth-onset T2DM has more rapid disease progression compared to adult-onset type 2 diabetes. It results in earlier and more severe microvascular and macrovascular complications compared to both adult-onset T2DM and youth-onset type 1 diabetes (T1DM). While there is a lack of data describing the socioeconomic cost of youth-onset T2DM, based on extrapolation from analyses of the burden of T2DM in adults and T1DM in youth, we propose that youth-onset T2DM has higher direct and indirect costs than adult-onset T2DM. SUMMARY: Youth-onset T2DM presents a significant clinical and socioeconomic burden due to its aggressive presentation and earlier appearance of complications. Additional research is needed regarding the cost of illness in this population.
format Online
Article
Text
id pubmed-10037371
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100373712023-03-24 Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost Rodriquez, Isabella Marranzini O’Sullivan, Katie L. Curr Diab Rep Article PURPOSE OF REVIEW: With the rise in prevalence of youth-onset type 2 diabetes (T2DM), it is imperative to understand the clinical burden of the disease and the socioeconomic burden this disease imposes. We review the most recent data on youth-onset T2DM, including its pathophysiology, complications, and treatment. We also review existing data to determine the socioeconomic burden of youth-onset T2DM. RECENT FINDINGS: The incidence of youth-onset T2DM is rising, and significantly accelerated following the COVID-19 pandemic. Youth with T2DM are more frequently from families of racial/ethnic minorities and lower socioeconomic status. Youth-onset T2DM has more rapid disease progression compared to adult-onset type 2 diabetes. It results in earlier and more severe microvascular and macrovascular complications compared to both adult-onset T2DM and youth-onset type 1 diabetes (T1DM). While there is a lack of data describing the socioeconomic cost of youth-onset T2DM, based on extrapolation from analyses of the burden of T2DM in adults and T1DM in youth, we propose that youth-onset T2DM has higher direct and indirect costs than adult-onset T2DM. SUMMARY: Youth-onset T2DM presents a significant clinical and socioeconomic burden due to its aggressive presentation and earlier appearance of complications. Additional research is needed regarding the cost of illness in this population. Springer US 2023-03-24 2023 /pmc/articles/PMC10037371/ /pubmed/36961664 http://dx.doi.org/10.1007/s11892-023-01501-7 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Rodriquez, Isabella Marranzini
O’Sullivan, Katie L.
Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost
title Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost
title_full Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost
title_fullStr Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost
title_full_unstemmed Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost
title_short Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost
title_sort youth-onset type 2 diabetes: burden of complications and socioeconomic cost
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037371/
https://www.ncbi.nlm.nih.gov/pubmed/36961664
http://dx.doi.org/10.1007/s11892-023-01501-7
work_keys_str_mv AT rodriquezisabellamarranzini youthonsettype2diabetesburdenofcomplicationsandsocioeconomiccost
AT osullivankatiel youthonsettype2diabetesburdenofcomplicationsandsocioeconomiccost